Q2 2025

Filed Aug 13, 2025 · 10-Q · 44 days after period end · 0001663577-25-000261

Q2 2025 · 10-Q

Revenue

$5.00K

±0.0% vs Q2 2024

Net Income

-$274.43K

N/M vs Q2 2024

EPS, diluted—

Gross Profit$5,000±0.0%

Operating Income-$136,237N/M

Same quarter

Metric	Q2 2025	Q2 2024	Q2 2023	Q2 2022
Revenue	$5.00K	$5.00K	$5.00K	$205.00K
Net Income	-$274.43K	-$303.45K	-$276.08K	-$191.72K
EPS Diluted	—	-$0.07	-$0.06	-$0.04

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Skinvisible, Inc. · CIK 1085277 · Engraved from SEC EDGAR